Aim To assess serum levels and correlation between uric acid (UA) and C-reactive protein (CRP) in acute coronary syndrome (ACS) and apparently healthy individuals. Methods The cross-sectional study included 116 examinees of age 44 to 83 years, distributed in two groups: 80 ACS patients including 40 with acute myocardial infarction (AMI), and 40 with unstable angina pectoris (UAP), and 36 apparently healthy (control group) individuals. Patients with ACS were hospitalized at the Cardiology Clinic, Clinical Centre Sarajevo in the period OctoberDecember 2012. Laboratory analyses were conducted by standard methods. The accepted statistical significance level was p<0.05. Results Serum levels of CRP and UA were higher in patients with ACS as compared to control group (p<0.01). The median serum UA was insignificantly lower, and CRP was significantly higher in patients with AMI compared to UAP (p=0.118 and p=0.001, respectively). Both CRP and UA correlated positively in both ACS and control groups (rho=0.246; p=0.028 and rho=0.374; p=0.027). A positive correlation between serum CRP and UA was noted in patients with AMI, but negative in patients with UAP (p>0.05). Conclusion The correlation between CRP and UA in the patients with ACS indicates the association of oxidative stress and inflammation intensity in damaged cardiomyocytes. Correlation between UA and CRP in apparently healthy individuals indicates a possible role of UA as a marker of low-grade inflammation and its potential in risk assessment in cardiovascular diseases.
Baruah M, Nath C, Chaudhury B, Devi R, Ivvala A. A study of serum uric acid and C-reactive protein in acute myocardial infarction. IJBMSP 2012;(Suppl 1):21–4.
2
Pozitivna. Zaključak Odnos CRP-a i MG-a u serumu oboljelih od AKS-a ukazuje na povezanost intenziteta oksidativnog stresa s intenzitetom inflamacije zahvaćenog dijela kardiomiocita. Povezanost vrijednosti MK-a i CRP-a u serumu naizgled zdravih ispitanika ukazuje na moguću ulogu MK-a kao markera intenziteta hronične inflamacije niskog stepena te predstavlja potencijal u procjeni rizika za razvoj kardiovaskularnih bolesti n.d.
3
Metode U presječnu studiju bilo je uključeno 116 ispitanika, starosne dobi između 44 i 83 godine, distribuiranih u dvije grupe: 80 ispitanika s AKS-om i to 40 s akutnim infarktom miokarda (AIM) i 40 s nestabilnom anginom pektoris (NAP) n.d.
4
Zdravlja D, Zenica. 3 Klinika za hemodijalizu, 4 Klinika za srce i reumatizam; Klinički centar Univerziteta u Sarajevu; Bosna i Hercegovina SAŽETAK Cilj Ispitati serumske vrijednosti i odnos između mokraćne kiseline (MK) i C-reaktivnog proteina (CRP) kod naizgled zdravih osoba i kod pacijenata s akutnim koronarnim sindromom (AKS) n.d.
Ndrepepa G, Braun S, Haase H, Schulz S, Ranftl S, Hadamitzky M, et al. Prognostic value of uric acid in patients with acute coronary syndromes. Am J Cardiol 2012;(Suppl 9):1260–5.
7
Sautin Y, Johnson Y. Uric Acid: The oxidant-antioxidant paradox. Nucleosides Nucleotides Nucleic Acids 2008;(Suppl 6):608–19.
8
Strazzullo P, Puig J. Uric acid and oxidative stress: relative impact on cardiovascular risk? Nutr Metab Cardiovasc Dis 2007;(Suppl 6):409–14.
9
Gur M, Yilmaz R, Demirbag R, Aksoy N. Relation of serum uric acid levels with the presence and severity of angiographic coronary artery disease. Angiology 2008;(Suppl 2):166–71.
10
Lagrand W, Visser C, Hermens W, Niessen H, Verheught F, Wolbink G. C-reactive protein as a cardiovascular risk factor; more than an epiphenomenon. Circulation 1999:96–102.
11
Munir T, Afzal M, Ahmed R. C-reactive protein and acute coronary syndrome: correlation with traditional risk factors, diagnostic cardiac biomarkers, and ejection fraction. RMJ 2009;(Suppl 2):154–9.
12
Yildiz H. High Sensitive C -reactive protein levels in patients with acute coronary syndrome. The Iraqi Postgraduate. Medical Journal 2013:643–9.
13
Swiatkiewicz I, Kozinski M, Magielski P, Fabiszak T, Sukiennik A, Navarese E, et al. Value of C-reactive protein in predicting left ventricular remodelling in patients with a first ST-segment elevation myocardial infarction. Mediators Inflamm 2012:250867.
14
Kushner I, Broder M, Karp D. Control of the acute phase response. Serum C-reactive protein kinetics after acute myocardial infarction. J Clin Invest 1998;(Suppl 2):235–42.
15
Shrivastava A, Singh HV, Raizada A, Singh S. C-reactive protein, inflammation and coronary heart disease. The Egyptian Heart Journal 2015:89–97.
16
Vidigal F, Rosado L, Rosado G, Ribeiro C. The high UA levels with increase of CRP and inflammation in the body can contribute to progression of atherosclerotic disease. C. Franceschini Sdo C. Nutr Hosp 2014;(Suppl 4):935–40.
17
Jalal D, Jablonski K, Mcfann K, Choncholand M, Seals D. Vascular Endothelial Function Is Not Related to Serum Uric Acid in Healthy Adults. Am J Hypertens 2012;(Suppl 4):407–13.
18
Niskanen L, Laaksonen D, Nyyssonen K, Alfthan G, Lakka H, Lakka T. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 2004;(Suppl 9):1546–51.
19
Hayden M, Tyagi S. Uric acid: a new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: the urate redox shuttle. Nutr Metab 2004;(Suppl 1):10.
20
Nieto F, Iribarren C, Gross M, Comstock G, Cutler R. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis. Atherosclerosis 2000;(Suppl 1):131–9.
21
Koenig W, Sund M, Frohlich M, Fischer H, Löwel H, Döring A. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Augsburg Cohort Study, 1984 to1992. Circulation 1999:237–42.
22
Yamada S, Gotoh T, Nakashima Y, Kayaba K, Ishikawa S, Nago N. Distribution of serum C-reactive Protein and Its Association with Atherosclerotic Risk Factors in a Japanese Population. Am J Epidemiol 2001;(Suppl 12):1183–9.
23
Pearson T, Mensah G, Alexander R, Anderson J, Cannon R, Iii, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for health care professionals from the Centers for Disease Con-dicate greater intensity of oxidative stress in ACS than in control group. Under local ischemia condition and increased synthesis of oxygen radicals, UA becomes prooxidant (22-24). trol and Prevention and the American Heart Association. Circulation 2003;(Suppl 3):499–511.
24
Silvaa D, Lacerda A. High-sensitivity C-reactive protein as a biomarker of risk in coronary artery disease. Rev Port Cardiol 2012;(11):733–45.
25
Car S. Serum concentration of uric acid and the outcome of acute coronary syndrome. Medical Faculty 2012.
26
Rodrigo R, Libuy M, Feliú F, Hasson D. Oxidative stress-related biomarkers in essential hypertension and ischemia-reperfusion myocardial damage. Dis Markers 2013;(Suppl 6):773–90.
27
Ridker P. High-sensitivity C-reactive protein: Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001:1813–8.
28
Matunović R, Stojanović A, Mijailović Z, Rađen G. Importance of determining biomarkers of myocardial necrosis in acute coronary syndrome. Vojnosanit Pregl 2005;(Suppl 5):403–8.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
